UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms

The Journal of experimental medicine, 2015-10, Vol.212 (11), p.1833-1850

2015

Volltextzugriff (PDF)

MYC protein expression in primary diffuse large B-cell lymphoma of the central nervous system

PloS one, 2014-12, Vol.9 (12), p.e114398-e114398

2014

Volltextzugriff (PDF)

Effects of High- and Low-LET Radiation on Human Hematopoietic System Reconstituted in Immunodeficient Mice

Radiation research, 2019-02, Vol.191 (2), p.162

2019

Volltextzugriff (PDF)

Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN

Blood advances, 2021-02, Vol.5 (4), p.1092-1096

2021

Volltextzugriff (PDF)

The genetic landscape of dural marginal zone lymphomas

Oncotarget, 2016-07, Vol.7 (28), p.43052-43061

2016

Volltextzugriff (PDF)

Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation

Human pathology, 2012-11, Vol.43 (11), p.1828-1838

2012

Volltextzugriff (PDF)

Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes

Blood advances, 2018-06, Vol.2 (12), p.1393-1402

2018

Volltextzugriff (PDF)

Pathologic and Clinical Features Of CD30+ Post-Transplant Lymphoproliferative Disorders: A Large Retrospective Single Institutional Study

Blood, 2013-11, Vol.122 (21), p.4333-4333

2013

Volltextzugriff (PDF)

Lymphoid follicle colonization by Bcl-2bright+ CD10+ B-cells (“follicular lymphoma in situ”) at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma

Human pathology, 2013-07, Vol.44 (7), p.1328-1340

2013

Volltextzugriff (PDF)

Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemia

Human pathology, 2012-12, Vol.43 (12), p.2354-2359

2012

Volltextzugriff (PDF)

EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab with Rituximab and Lenalidomide (R 2) Vs R 2 Alone in Patients with Relapsed or Refractory Follicular Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.3053-3053

2023

Volltextzugriff (PDF)

Commentary on "Small cell lung cancer: time to diagnosis and treatment"

Southern medical journal (Birmingham, Ala.), 2012-08, Vol.105 (8), p.424-425

Hoehn, Daniela

2012

Volltextzugriff (PDF)

KEYNOTE-B61: Open-label phase 2 study of pembrolizumab in combination with lenvatinib as first-line treatment for non-clear cell renal cell carcinoma (nccRCC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS4595-TPS4595

2021

Volltextzugriff (PDF)

Epcoritamab with rituximab + lenalidomide (R 2 ) in previously untreated (1L) follicular lymphoma (FL) and epcoritamab maintenance in FL: EPCORE NHL-2 arms 6 and 7

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.7014-7014

2024

Volltextzugriff (PDF)

Epcoritamab SC + R-Mini-CHOP Leads to High Complete Metabolic Response Rates in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: First Disclosure from Arm 8 of the Epcore NHL-2 Trial

Blood, 2023-11, Vol.142 (Supplement 1), p.4457-4457

2023

Volltextzugriff (PDF)

Laparoscopic Management of Peritoneal Mesothelioma Associated with Pelvic Endometriosis

Journal of minimally invasive gynecology, 2010-09, Vol.17 (5), p.646-650

2010

Volltextzugriff (PDF)

EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL

Journal of clinical oncology, 2024, Vol.42 (16_suppl), p.7015-7015

2024

Volltextzugriff (PDF)

Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1)

Blood, 2022-11, Vol.140 (Supplement 1), p.850-851

2022

Volltextzugriff (PDF)

Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma

Clinical cancer research, 2015-10, Vol.21 (20), p.4663-4675

2015

Volltextzugriff (PDF)

The Effect of High LET Space Radiation on the Human Hematopoietic System: Preliminary Results from the First In Vivo Model

Blood, 2015-12, Vol.126 (23), p.5416-5416

2015

Volltextzugriff (PDF)

Managing Acute Myeloid Leukemia in Older Patients: Are We Making Progress? An Analysis of Treatment Patterns and Healthcare Resource Utilization

Blood, 2017-12, Vol.130, p.4714-4714

2017

Volltextzugriff (PDF)

Treatment Patterns of Hypomethylating Agents in Older (≥65 Years) Acute Myeloid Leukemia Patients Who Did Not Receive Intensive Chemotherapy: A Retrospective Claims Database Analysis

Blood, 2017-12, Vol.130, p.5600-5600

2017

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(85)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms

Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene

MYC protein expression in primary diffuse large B-cell lymphoma of the central nervous system

Effects of High- and Low-LET Radiation on Human Hematopoietic System Reconstituted in Immunodeficient Mice

Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN

The genetic landscape of dural marginal zone lymphomas

Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation

Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes

Pathologic and Clinical Features Of CD30+ Post-Transplant Lymphoproliferative Disorders: A Large Retrospective Single Institutional Study

Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study

Lymphoid follicle colonization by Bcl-2bright+ CD10+ B-cells (“follicular lymphoma in situ”) at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma

Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemia

Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial

EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab with Rituximab and Lenalidomide (R 2) Vs R 2 Alone in Patients with Relapsed or Refractory Follicular Lymphoma

Commentary on "Small cell lung cancer: time to diagnosis and treatment"

KEYNOTE-B61: Open-label phase 2 study of pembrolizumab in combination with lenvatinib as first-line treatment for non-clear cell renal cell carcinoma (nccRCC)

Epcoritamab with rituximab + lenalidomide (R 2 ) in previously untreated (1L) follicular lymphoma (FL) and epcoritamab maintenance in FL: EPCORE NHL-2 arms 6 and 7

Epcoritamab SC + R-Mini-CHOP Leads to High Complete Metabolic Response Rates in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: First Disclosure from Arm 8 of the Epcore NHL-2 Trial

Laparoscopic Management of Peritoneal Mesothelioma Associated with Pelvic Endometriosis

EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL

Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1)

Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma

The Effect of High LET Space Radiation on the Human Hematopoietic System: Preliminary Results from the First In Vivo Model

Managing Acute Myeloid Leukemia in Older Patients: Are We Making Progress? An Analysis of Treatment Patterns and Healthcare Resource Utilization

Treatment Patterns of Hypomethylating Agents in Older (≥65 Years) Acute Myeloid Leukemia Patients Who Did Not Receive Intensive Chemotherapy: A Retrospective Claims Database Analysis

Suchergebnisse filtern